出海提速+降本增效，楚天科技业绩与股价齐飞

Core Viewpoint - Chutian Technology has returned to profitability in Q3, achieving significant revenue growth and a substantial increase in net profit compared to the previous year [1][2]. Financial Performance - For the first nine months of the year, the company reported revenue of 3.896 billion yuan and a net profit of 84.4635 million yuan, marking a year-on-year increase of 145.11% [1]. - In Q3 alone, revenue reached 1.479 billion yuan, up 10.17% year-on-year, with a profit of 96.7681 million yuan, reflecting a 192.5% increase [1]. Strategic Adjustments - Since the second half of last year, the company has actively adjusted its business strategy, focusing on international market expansion and reducing low-margin and loss-making projects [1]. - Chutian Technology has implemented cost-reduction and efficiency-enhancement measures, effectively lowering overall operational costs [1]. Market Expansion - The company has segmented its global market into five regions, including East Asia, Southeast Asia, Europe, and the Americas, tailoring sales services to local characteristics [1][2]. - Recent international initiatives include hosting the 2025 Vietnam Biopharmaceutical Summit and participating in the World Pharmaceutical Raw Materials and Machinery Exhibition in Frankfurt, Germany [2]. Stock Market Performance - Following the positive financial results, Chutian Technology's stock surged, reaching a 20% limit-up on October 28, closing at 11.32 yuan, with a year-to-date increase of over 65% [3].